The Coca-Cola Co K vs Relay Therapeutics Inc. Common Stock — how do they compare? The Coca-Cola Co K trades at $87.76 (market cap $377.63B), while Relay Therapeutics Inc. Common Stock trades at $18.03 (market cap $3.82B). The key difference: The Coca-Cola Co K is far larger — about 98.9× Relay Therapeutics Inc. Common Stock's market cap, and The Coca-Cola Co K pays a 2.42% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold The Coca-Cola Co K for 154 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| KO | RLAY | |
|---|---|---|
Market Cap | $377.63B | $3.82B |
Volume | 14,894,568 | 4,332,079 |
Sector | Consumer Staples | Health |
52-Week High | $91.99 | $20.75 |
52-Week Low | $66.37 | $6.03 |
Typical Hold Time | 154 Days | 0 Days |
Enterprise Value | $404.81B | $2.93B |
Dividend Yield | 2.42% | — |
Signals from Pluang's Aura AI — not financial advice
Coca-Cola (KO) trades at $87.97, up 2.51% today, with a bullish technical outlook supported by moving averages and recent earnings beats. The company reported strong profitability with a 28.56% net income margin and a 44.23% ROE for 2025. Analyst consensus is a Buy with a $95.75 price target, and institutional buying activity is evident in recent news. The stock is positioned near key resistance at $88, with support at $87.
The outlook for KO is positive, driven by consistent earnings performance and a strong dividend history, but risks include high valuation multiples and regional demand volatility. The stock offers stability with growth potential, though investors should monitor debt levels and competitive pressures in the beverage industry.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →